Security key
45783C101
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL)
CUSIP: 45783C101
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.000001 par value per share
- Total 13F shares
- 1,899,004
- Total 13F value
- $36,251,986
- Share change
- 0
- SEC-reported price per share
- $19.09
- Number of holders
- 1
- Shares outstanding
- 6,795,789
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
1
Top holders
1
TIL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Instil Bio, Inc. SEC filings
Instil Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45783C101
Recent filing periods:
Ownership snapshot
Top reported holders of TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Curative Ventures V LLC
Disclosed value leader
Curative Ventures V LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 28%
Showing 1-6 of 15 holder rows.
Quick read
Curative Ventures V LLC leads the comparable SEC ownership view at 28%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Curative Ventures V LLC's linked filing trail.
Comparable ownership
Top 5
Curative Ventures V LLC
28%
Vivo Capital, LLC
9.6%
CPMG Inc
6.3%
Boxer Capital, LLC
5.5%
PERCEPTIVE ADVISORS LLC
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Curative Ventures V LLC |
13F
Company
|
28%
|
$127,840,949
1,899,004 shares
|
— | 30 Sep 2024 |
| Vivo Capital, LLC |
13F
Company
|
9.6%
|
$42,030,501
624,339 shares
|
— | 30 Sep 2024 |
| CPMG Inc |
13F
Company
|
6.3%
|
$27,663,269
410,922 shares
|
— | 30 Sep 2024 |
| Boxer Capital, LLC |
13F
Company
|
5.5%
|
$23,932,260
355,500 shares
|
— | 30 Sep 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
5.3%
|
$23,262,089
345,545 shares
|
— | 30 Sep 2024 |
| BML Capital Management, LLC |
13F
Company
|
5.1%
|
$22,552,200
335,000 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
1,899,004
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
1
Q4 2024 holders
1
Holder diff
0
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend